InnoCare Pharma (688428.SH) awarded 8 million restricted shares to 100 incentive recipients.
Nuo Cheng Jianhua (688428.SH) announced that the company's board of directors approved the proposal of "Granting Restricted Stock to Incentive Objectives for the First Time Under the 2026 Sci-Tech Innovation Board Restricted Stock Incentive Plan" on June 16, 2026. The first grant date of this incentive plan was also set as June 16, 2026. The company will grant 8 million shares of restricted stock to 100 eligible incentive objects at a price of 14.47 yuan per share.
InnoCare Pharma (688428.SH) announced that the board of directors approved the proposal to grant 8 million restricted shares at a price of 14.47 yuan per share to 100 eligible incentive recipients under the 2026 Sci-Tech Innovation Board Restricted Stock Incentive Plan during a meeting held on June 16, 2026. The grant date for the incentive plan was also set as June 16, 2026.
Related Articles
HUSCOKE Holdings (00704): Delay in publishing the full-year performance announcement for 2025/26.
Yuzhou Group (01628) plans to sell Hong Kong properties for approximately HK$269 million.
On June 16, HOMELAND ITL (03798) spent about HK$277,200 to repurchase 196,000 shares.
HUSCOKE Holdings (00704): Delay in publishing the full-year performance announcement for 2025/26.
Yuzhou Group (01628) plans to sell Hong Kong properties for approximately HK$269 million.
On June 16, HOMELAND ITL (03798) spent about HK$277,200 to repurchase 196,000 shares.
RECOMMEND
